German biotech firm starts human trials of experimental COVID-19 vaccine | WION-DW Partnership

Jun 19, 2020, 10:45 PM(IST)

Unlisted biotech firm CureVac on Wednesday become the second company after rival BioNTech to launch human trials of an experimental coronavirus vaccine in Germany, eyeing potential regulatory approval in mid-2021.

Read in App